| Ms Gia Nina Scarpetta, MS- CCC | |
|
1111 Menaul Blvd Ne, Albuquerque, NM 87107-1614 | |
| (505) 255-5501 | |
| (505) 255-9971 |
| Full Name | Ms Gia Nina Scarpetta |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1111 Menaul Blvd Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184740193 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 4064 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Gia Nina Scarpetta, MS- CCC 1615 Stanford Dr Ne, Albuquerque, NM 87106-3729 Ph: (505) 256-2574 | Ms Gia Nina Scarpetta, MS- CCC 1111 Menaul Blvd Ne, Albuquerque, NM 87107-1614 Ph: (505) 255-5501 |
News Archive
An Australian-first plan to boost primary care research and drive improved patient outcomes, has been backed by $1 million in grant funding.
Compared to a survey conducted nearly 20 years ago, about twice the proportion of addiction counselors now find it acceptable for at least some of their patients to have a drink occasionally - either as an intermediate goal or as their final treatment goal, according to a new study published by the American Psychological Association.
Patients are more likely to receive colorectal cancer screening when primary care practices use an office systems approach, according to an article in the March 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (sBLA) providing regular approval for Soliris® (eculizumab) for the treatment of adult and pediatric patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA).
UT Southwestern Medical Center researchers have developed an MRI-based method that can track the state and progression of a common type of genetically mutated brain cancer.
› Verified 1 days ago
Elizabeth Y Kam, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7801 Candelaria Rd Ne, Sandia Hs, Albuquerque, NM 87110 Phone: 505-294-1511 | |
Ms. Brittney Amber Martinez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10800 Comanche Rd Ne Apt 329, Albuquerque, NM 87111 Phone: 505-927-8291 Fax: 505-266-6306 | |
Breanna White, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9500 Montgomery Blvd Ne Ste 215, Albuquerque, NM 87111 Phone: 505-247-4224 | |
Tyler Brewer, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6811 Taylor Ranch Rd Nw, Albuquerque, NM 87120 Phone: 505-898-1492 | |
Leslie Guzman, SLP-CF Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6400 Uptown Blvd Ne, Suite 360w, Albuquerque, NM 87110 Phone: 505-855-9805 Fax: 505-848-9468 | |
Samantha Vance, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6400 Uptown Blvd Ne Ste 360, Albuquerque, NM 87110 Phone: 505-299-9010 | |
Marsha Grover, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 412 Alameda Blvd Nw, Alameda Es, Albuquerque, NM 87114 Phone: 505-898-0070 |